The GSK data set is pretty close to getting a randomized trial the way NHS in the UK implemented Shingrix vaccine eligibility. The difference in long term follow-up data is pretty stark.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.